Home
/
Chemours Co
/
Financials
/
Quarterly
Chemours Co — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Chemours Co filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2018
Mar 31, 2018
$1.73B
May 4, 2018
Q3
2017
Sep 30, 2017
$1.58B
Nov 3, 2017
Q2
2017
Jun 30, 2017
$1.59B
Aug 3, 2017
Q1
2018
Mar 31, 2017
$1.44B
May 4, 2018
Q3
2017
Sep 30, 2016
$1.40B
Nov 3, 2017
Q2
2017
Jun 30, 2016
$1.38B
Aug 3, 2017
Q1
2017
Mar 31, 2016
$1.30B
May 3, 2017
Q3
2016
Sep 30, 2015
$1.49B
Nov 7, 2016
Q2
2015
Jun 30, 2015
$1.51B
Aug 6, 2015
Q3
2015
Sep 30, 2014
$1.63B
Nov 5, 2015
Q2
2015
Jun 30, 2014
$1.68B
Aug 6, 2015
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$1.50B
Nov 6, 2025
Q2
2025
Jun 30, 2025
$1.62B
Aug 5, 2025
Q1
2025
Mar 31, 2025
$1.37B
May 6, 2025
Q3
2025
Sep 30, 2024
$1.51B
Nov 6, 2025
Q1
2025
Sep 30, 2024
$1.51B
May 6, 2025
Q2
2025
Jun 30, 2024
$1.55B
Aug 5, 2025
Q1
2025
Jun 30, 2024
$1.55B
May 6, 2025
Q1
2025
Mar 31, 2024
$1.36B
May 6, 2025
Q3
2024
Sep 30, 2023
$1.49B
Nov 4, 2024
Q2
2024
Jun 30, 2023
$1.64B
Aug 1, 2024
Q1
2024
Mar 31, 2023
$1.54B
Apr 30, 2024
Q3
2023
Sep 30, 2022
$1.78B
Oct 27, 2023
Q2
2023
Jun 30, 2022
$1.92B
Jul 28, 2023
Q1
2023
Mar 31, 2022
$1.76B
Apr 28, 2023
Q3
2022
Sep 30, 2021
$1.68B
Oct 26, 2022
Q2
2022
Jun 30, 2021
$1.66B
Aug 1, 2022
Q1
2022
Mar 31, 2021
$1.44B
May 3, 2022
Q3
2021
Sep 30, 2020
$1.23B
Nov 5, 2021
Q2
2021
Jun 30, 2020
$1.09B
Jul 30, 2021
Q1
2021
Mar 31, 2020
$1.31B
May 5, 2021
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2018
Mar 31, 2018
$1.73B
May 4, 2018
Q3
2017
Sep 30, 2017
$1.58B
Nov 3, 2017
Q2
2017
Jun 30, 2017
$1.59B
Aug 3, 2017
Q1
2018
Mar 31, 2017
$1.44B
May 4, 2018
Q3
2017
Sep 30, 2016
$1.40B
Nov 3, 2017
Q2
2017
Jun 30, 2016
$1.38B
Aug 3, 2017
Q1
2017
Mar 31, 2016
$1.30B
May 3, 2017
Q3
2016
Sep 30, 2015
$1.49B
Nov 7, 2016
Q2
2016
Jun 30, 2015
$1.51B
Aug 9, 2016
Q1
2016
Mar 31, 2015
$1.36B
May 9, 2016
Q3
2015
Sep 30, 2014
$1.63B
Nov 5, 2015
Q2
2015
Jun 30, 2014
$1.68B
Aug 6, 2015
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$60.00M
Nov 6, 2025
Q2
2025
Jun 30, 2025
($381.00M)
Aug 5, 2025
Q1
2025
Mar 31, 2025
($4.00M)
May 6, 2025
Q1
2025
Dec 31, 2024
$70.00M
May 6, 2025
Q3
2025
Sep 30, 2024
($32.00M)
Nov 6, 2025
Q1
2025
Sep 30, 2024
($32.00M)
May 6, 2025
Q2
2025
Jun 30, 2024
$60.00M
Aug 5, 2025
Q1
2025
Jun 30, 2024
$60.00M
May 6, 2025
Q1
2025
Mar 31, 2024
$54.00M
May 6, 2025
Q3
2024
Sep 30, 2023
$12.00M
Nov 4, 2024
Q2
2024
Jun 30, 2023
($376.00M)
Aug 1, 2024
Q1
2024
Mar 31, 2023
$145.00M
Apr 30, 2024
Q3
2023
Sep 30, 2022
$240.00M
Oct 27, 2023
Q2
2023
Jun 30, 2022
$201.00M
Jul 28, 2023
Q1
2023
Mar 31, 2022
$234.00M
Apr 28, 2023
Q3
2022
Sep 30, 2021
$214.00M
Oct 26, 2022
Q2
2022
Jun 30, 2021
$66.00M
Aug 1, 2022
Q1
2022
Mar 31, 2021
$96.00M
May 3, 2022
Q3
2021
Sep 30, 2020
$76.00M
Nov 5, 2021
Q2
2021
Jun 30, 2020
$24.00M
Jul 30, 2021